Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix

J Infect Dis. 2000 Jun;181(6):1950-6. doi: 10.1086/315514. Epub 2000 May 31.

Abstract

To address the hypothesis that local immune activation resulting from genital ulceration enhances human immunodeficiency virus type 1 (HIV-1) replication and shedding into the genital tract, paired plasma and cervicovaginal lavage (CVL) samples were obtained from 12 HIV-infected women before and after treatment of cervical intraepithelial lesions. Two weeks after treatment, inflammation and ulceration of the cervix were accompanied by major increases in mean concentrations of HIV-1 RNA (200-fold), tumor necrosis factor-alpha, interleukin 6, and soluble markers shed by activated lymphocytes and macrophages (sCD25 and sCD14, respectively) in CVL samples (P<.01 for each), but not plasma. Strong temporal and quantitative correlations were observed between concentrations of immunological markers and HIV-1 load in this compartment during a 10-week follow-up. Furthermore, in the presence of genital ulceration, HIV-1 in CVL samples was more readily captured by antibodies directed against virion-associated HLA-DR, a marker of host-cell activation, compared with virus in plasma. We suggest that local immune activation increases HIV-1 load in genital secretions, potentially increasing the risk of HIV-1 transmission.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Genitalia, Female / virology*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification*
  • HLA-DR Antigens / analysis
  • Humans
  • Interleukin-6 / analysis
  • Lipopolysaccharide Receptors / analysis
  • RNA, Viral / analysis*
  • Receptors, Interleukin-2 / analysis
  • Tumor Necrosis Factor-alpha / analysis
  • Ulcer / immunology
  • Ulcer / virology*
  • Uterine Cervical Diseases / immunology
  • Uterine Cervical Diseases / virology*
  • Uterine Cervical Dysplasia / therapy
  • Uterine Cervical Dysplasia / virology

Substances

  • HLA-DR Antigens
  • Interleukin-6
  • Lipopolysaccharide Receptors
  • RNA, Viral
  • Receptors, Interleukin-2
  • Tumor Necrosis Factor-alpha